7CI Stock Overview
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cronos Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.36 |
| 52 Week High | CA$3.10 |
| 52 Week Low | CA$1.48 |
| Beta | 1.12 |
| 1 Month Change | 0.60% |
| 3 Month Change | 30.68% |
| 1 Year Change | 51.87% |
| 3 Year Change | -65.95% |
| 5 Year Change | -85.03% |
| Change since IPO | 4.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7CI | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 3.7% | 3.2% | 1.7% |
| 1Y | 51.9% | -28.2% | 2.3% |
Return vs Industry: 7CI exceeded the German Pharmaceuticals industry which returned -27.7% over the past year.
Return vs Market: 7CI exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| 7CI volatility | |
|---|---|
| 7CI Average Weekly Movement | 11.6% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7CI's share price has been volatile over the past 3 months.
Volatility Over Time: 7CI's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 356 | Mike Gorenstein | www.thecronosgroup.com |
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Cronos Group Inc. Fundamentals Summary
| 7CI fundamental statistics | |
|---|---|
| Market cap | €885.81m |
| Earnings (TTM) | -€65.27m |
| Revenue (TTM) | €81.52m |
10.9x
P/S Ratio-13.6x
P/E RatioIs 7CI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7CI income statement (TTM) | |
|---|---|
| Revenue | US$87.24m |
| Cost of Revenue | US$75.33m |
| Gross Profit | US$11.91m |
| Other Expenses | US$81.76m |
| Earnings | -US$69.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | 13.65% |
| Net Profit Margin | -80.06% |
| Debt/Equity Ratio | 0% |
How did 7CI perform over the long term?
See historical performance and comparison